![Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/19d18b551749aea8e37f4e3032ca2f1f50bcb710/7-Figure4-1.png)
Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar
![Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases | Semantic Scholar Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5521387d104a5f94ab7a6167f643ed17625ba1c5/4-Figure4-1.png)
Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases | Semantic Scholar
![Drug Store News on X: "Alembic has launched a timolol maleate ophthalmic gel-forming solution, which is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Drug Store News on X: "Alembic has launched a timolol maleate ophthalmic gel-forming solution, which is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.](https://pbs.twimg.com/media/Er0mya9XUAA-K8l.png)